IncFact
Company Profiles: Revenue, Growth, Competition

RARECYTE Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Rarecyte

Access the complete profile.

Rarecyte Fast Facts

Revenue$10 - $50 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes33911
4234 Professional & Commercial Equipment & Supplies Merchant Wholesalers
5417 Scientific Research & Development Services
Address2601 4th Ave Ste 500
Seattle, WA 98121

www.rarecyte.com
Note: Revenues for privately held companies are statistical evaluations.


Rarecyte's annual revenues are $10-$50 million (see exact revenue data). It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.


Rarecyte's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Rarecyte Annual Revenue and Growth Rate

Rarecyte Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Rarecyte's revenues are gauged from an analysis of company filings.



Investor Activity

Rarecyte has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
December 26, 2019 0 100%$22 MM
Complete list of funding rounds and total amounts in the Company Report




Rarecyte's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Rarecyte Revenue (Sales) Rarecyte Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Rarecyte is developing and marketing. Rarecyte's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PICK-SEQ
Assays for research purposes
02/25/2019
CYTEHUB
Computer software for analysis of biological samples; computer software for accessing, editing, and reviewing files and settings associated with scanning, analysis, reviewing, and reporting of biological samples; computer software for setting or designating scan parameters, managing scan results, managing users, and launching additional applications associated with biological sample analysis
10/05/2018
TISSUEPLEX
Assays for research purposes
08/30/2018

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Rarecyte grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Rarecyte is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Surgical & Medical Instrument Manufacturing

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Rarecyte's Largest Competitors

A competitive analysis shows these companies are in the same general field as Rarecyte, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
GAUMARD SCIENTIFICMiami, FL100 
MHC MEDICAL PRODUCTSCincinnati, OH77 
BIODERMLargo, FL16 
PROVIDENCE MEDICAL TECHNOLOGYPleasanton, CA15 
ALLIANCE PARTNERSSan Antonio, TX12 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA11 
ARMAMENTARIUMSpring, TX8 
ALTA MEDICAL SPECIALTIESSalt Lake City, UT7 
SKY MEDICALSunrise, FL5 




Nearby Competitors

These companies are similar in business line and location to Rarecyte. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
NANOSTRING TECHNOLOGIESSeattle, WA100 
RARECYTESeattle, WA15 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA10 
BODYPOINT DESIGNSSeattle, WA7 
HOHMANNSeattle, WA4 
BENESOLBainbridge Island, WA3 




Future Competition: Rarecyte's Fastest Growing Competitors

These companies are in the same general field as Rarecyte and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Rarecyte Competitors